| Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype C Brendel, S Guda, R Renella, DE Bauer, MC Canver, YJ Kim, ... The Journal of clinical investigation 126 (10), 3868-3878, 2016 | 167 | 2016 |
| miRNA-embedded shRNAs for lineage-specific BCL11A knockdown and hemoglobin F induction S Guda, C Brendel, R Renella, P Du, DE Bauer, MC Canver, JK Grenier, ... Molecular Therapy 23 (9), 1465-1474, 2015 | 134 | 2015 |
| Preclinical evaluation of a novel lentiviral vector driving lineage-specific BCL11A knockdown for sickle cell gene therapy C Brendel, O Negre, M Rothe, S Guda, G Parsons, C Harris, ... Molecular Therapy-Methods & Clinical Development 17, 589-600, 2020 | 50 | 2020 |
| Elicitation of forskolin in suspension cultures of Coleus forskohlii (willd.) Briq. using elicitors of fungal origin G Swaroopa, M Anuradha, T Pullaiah Current Trends in Biotechnology and Pharmacy 7 (3), 755-762, 2013 | 11 | 2013 |
| DROSHA knockout leads to enhancement of viral titers for vectors encoding miRNA-adapted shRNAs HH Park, R Triboulet, M Bentler, S Guda, P Du, H Xu, RI Gregory, ... Molecular Therapy-Nucleic Acids 12, 591-599, 2018 | 6 | 2018 |
| Germplasm conservation of selected lines of Coleus forskohlii (Willd.) Briq by nodal segment encapsulation. G Swaroopa, NN Nimisha Nigam, AM Anuradha Maniyam | 6 | 2007 |
| Elicitation of forskolin in suspension cultures of Coleus forskohlii (Willd.) Briq. using bacterial elicitors G Swaroopa, M Anuradha, T Pullaiah The Journal of Indian Botanical Society 92 (1and2), 97-100, 2013 | 5 | 2013 |
| Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe disease Y Dogan, CN Barese, JW Schindler, JK Yoon, Z Unnisa, S Guda, ... Molecular Therapy-Methods & Clinical Development 27, 464-487, 2022 | 4 | 2022 |
| Influence of sucrose and plant growth regulators on growth and forskolin production in callus cultures of Coleus forskohlii G Swaroopa, M Anuraadha, T Pullaiah Current trends in biotechnology and pharmacy 10 (1), 46-55, 2016 | 4 | 2016 |
| Optimization of Bcl11a Knockdown by miRNA scaffold embedded shrnas leading to enhanced induction of fetal hemoglobin in erythroid cells for the treatment of beta-hemoglobinopathies C Brendel, S Guda, R Renella, P Du, DE Bauer, MC Canver, SC Kamran, ... Blood 124 (21), 2150, 2014 | 3 | 2014 |
| Optimization of lentivirus vector RNA polymerase II driven microRNA embedded shRNAs for enhanced processing and efficient knockdown of Bcl11a for induction of fetal hemoglobin … S Guda, D Peng, DE Bauer, R Renella, SC Kamran, J Thornton, ... MOLECULAR THERAPY 22, S207-S207, 2014 | 3 | 2014 |
| Hematopoietic SIN lentiviral micro RNA-mediated silencing of BCL11A: pre-clinical evidence for a sickle cell disease gene-therapy trial R Renella, A Perlov, CE Harris, DE Bauer, J Xu, S Guda, MD Milsom, ... Blood 120 (21), 753, 2012 | 3 | 2012 |
| Screening of Chimeric GAA Variants in a Preclinical Study of Pompe Disease Results in Candidate Vector for Hematopoietic Stem Cell Gene Therapy Y Dogan, CN Barese, JW Schindler, JK Yoon, Z Unnisa, S Guda, ... bioRxiv, 2021.12. 28.474352, 2021 | 2 | 2021 |
| Elicitation of Forskolin in suspension cultures of coleus forskohlii Willd Briq G Swaroopa Guntur, 2008 | 1 | 2008 |
| Preclinical lentiviral vector-mediated hematopoietic stem and progenitor cell gene therapy corrects Pompe disease-related muscle and neurological manifestations JK Yoon, JW Schindler, M Loperfido, C Baricordi, MP DeAndrade, ... bioRxiv, 2023.11. 03.565442, 2023 | | 2023 |
| Long-term hematopoietic stem cell lentiviral gene therapy rescues neuromuscular manifestations in preclinical study of Pompe disease mice NP van Til, JW Schindler, JK Yoon, Y Dogan, C Barese, Z Unnisa, S Guda, ... Molecular Genetics and Metabolism 135 (2), S122-S123, 2022 | | 2022 |
| Long-Term Hematopoietic Stem Cell Lentiviral Gene Therapy Corrects Neuromuscular Manifestations in Preclinical Study of Pompe Mice NP van Til, Y Dogan, C Barese, Z Unnisa, S Guda, R Schindler, J Yoon, ... MOLECULAR THERAPY 29 (4), 23-24, 2021 | | 2021 |
| Long-term hematopoietic stem cell gene therapy corrects neuromuscular manifestations in preclinical study of Pompe mice NP van Til, Y Dogan, C Barese, Z Unnisa, S Guda, R Schindler, J Yoon, ... Molecular Genetics and Metabolism 132 (2), S107, 2021 | | 2021 |
| Hematopoietic Stem Cell Gene Therapy Corrects Neuromuscular Manifestations in Preclinical Study of Pompe Mice NP van Til, Y Dogan, C Barese, Z Unnisa, S Guda, R Schindler, J Yoon, ... MOLECULAR THERAPY 28 (4), 402-402, 2020 | | 2020 |
| Improved bcl11a micrornas for treating hemoglobinopathies DA Williams, G Swaroopa | | 2019 |
